In today’s Pharmaceutical Executive Daily, Regeneron launches a $150 million gene editing collaboration with Tessera Therapeutics, the FDA begins agency-wide deployment of new agentic AI tools, and a new report suggests Richard Pazdur is stepping down as director of CDER.

Pharmaceutical Executive Daily: FDA's Agentic AI Deployment

<div>The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and <a href="http://PharmExec.com">PharmExec.com</a> to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. </div>

Science

Life Sciences

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and <a href="http://PharmExec.com" rel="noopener noreferrer">PharmExec.com</a> to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.&nbsp;

Share Pharmaceutical Executive Daily: FDA's Agentic AI Deployment

Sign up to save your podcasts

Pharmaceutical Executive Daily: FDA's Agentic AI Deployment

Pharmaceutical Executive Daily: FDA's Agentic AI Deployment

More shows like Pharmaceutical Executive

Planet Money

Economist Podcasts

Motley Fool Money

WSJ Your Money Briefing

WSJ What’s News

Bloomberg Businessweek

WSJ Tech News Briefing

HBR IdeaCast

Bold Names

The Indicator from Planet Money

The Readout Loud

Thoughts on the Market

The Journal.

Bloomberg Daybreak: US Edition

WSJ's Take On the Week